GLYCAN BIOSCIENCES LLC has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and computer technology are ENDOTIS PHARMA, GENSIA SICOR and CELGENE INT SARL.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | United States | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | China | 1 | |
#5 | Israel | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Computer technology | |
#4 | Measurement | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Kett Warren Charles | 7 |
#2 | Coombe Deirdre Roma | 5 |
#3 | Chen Yugang | 5 |
#4 | Basic Bruno | 2 |
#5 | Payne Alan David | 2 |
#6 | Mohamed Shifaza | 2 |
#7 | Mulloy Barbara | 1 |
#8 | Kett Warren | 1 |
#9 | Coombe Deirdre | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018068090A1 | Therapeutic agents and methods of producing same | |
AU2015261612A1 | Anionic conjugates of glycosylated bacterial metabolite | |
AU2014200346A1 | Sulphated xylans for treatment or prophylaxis of respiratory diseases | |
US2013281318A1 | Selection of medicaments that modulate the function and activity of interleukin 13 | |
AU2009299118A1 | Anionic conjugates of glycosylated bacterial metabolite | |
AU2009299119A1 | Anionic oligosaccharide conjugates |